X-ray repair cross-complementing group 4 (XRCC4) promoter -1394*T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma

Fertility and Sterility

Volumn 90, Issue 4 SUPPL., 2008, Pages 1417-1423

  Hsieh, Yao Yuan ^a   Chang, Chi Chen ^a   Bau, Da Tian ^a,b   Yeh, Lian Shen ^a   Tsai, Fuu Jen ^a,b   Tsai, Chang Hai ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

DNA repair; leiomyoma; polymorphism; xeroderma pigmentosum; XRCC4

Indexed keywords

TUMOR MARKER; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA REPAIR; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MYOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; XPD GENE; XRCC4 GENE;

CODON; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; LEIOMYOMA; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 52949109847     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.038     Document Type: Article

References (38)

1. Cramer D.W. Epidemiology of myomas. Semin Reprod Endocrinol 10 (1992) 320-324
2. Townsend D.E., Sparkes R.S., Baluda M.C., and McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107 (1970) 1168-1173
3. Rein M.S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 108 Suppl 5 (2000) 791-793
4. Tomescu D., Kavanagh G., Ha T., Campbell H., and Melton D.W. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22 (2001) 403-408
5. Park J.Y., Park S.H., Choi J.E., Lee S.Y., Jeon H.S., Cha S.I., et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 993-997
6. Gu J., Lu H., Tippin B., Shimazaki N., Goodman M.F., and Lieber M.R. XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps. EMBO J 26 (2007) 1010-1023
7. Bau D.T., Fu Y.P., Chen S.T., Cheng T.C., Yu J.C., Wu P.E., et al. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res 64 (2004) 5013-5019
8. Allen-Brady K., Cannon-Albright L.A., Neuhausen S.L., and Camp N.J. A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 1306-1310
9. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399 (1999) 700-704
10. Rybicki B.A., Conti D.V., Moreira A., Cicek M., Casey G., and Witte J.S. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 23-29
11. Rosell R., Taron M., Ariza A., Barnadas A., Mate J.L., Reguart N., et al. Molecular predictors of response to chemotherapy in lung cancer. Semin Oncol 31 (2004) 20-27
12. Hsieh Y.Y., Chang C.C., Tsai F.J., Hsu C.M., Lin C.C., and Tsai C.H. The C-related genotype and allele for E-cadherin 3′-UTR Pml I polymorphism are associated with higher susceptibility to endometriosis. Genet Mol Biol 28 (2005) 661-664
13. Jiao L., Bondy M.L., Hassan M.M., Wolff R.A., Evans D.B., Abbruzzese J.L., et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 30 (2006) 284-291
14. Takahashi K., Kawamura N., Tsujimura A., Ichimura T., Ito F., Ishiko O., et al. Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7. Int J Oncol 18 (2001) 1259-1263
15. Brosens I., Johannisson E., Dal Cin P., Deprest J., and Van den Berghe H. Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females. Fertil Steril 66 (1996) 376-379
16. Kyo S., Kanaya T., Ishikawa H., Ueno H., and Inoue M. Telomerase activity in gynecological tumors. Clin Cancer Res 2 (1996) 2023-2028
17. Khan S.G., Muniz-Medina V., Shahlavi T., Baker C.C., Inui H., Ueda T., et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 30 (2002) 3624-3631
18. Ide F., Kitada M., Sakashita H., Kusama K., Tanaka K., and Ishikawa T. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 163 (2003) 1729-1733
19. Rosell R., Crino L., Danenberg K., Scagliotti G., Bepler G., Taron M., et al. Targeted therapy in combination with gemcitabine in non-small cell lung cancer. Semin Oncol 30 (2003) 19-25
20. Hou S.M., Falt S., Angelini S., Yang K., Nyberg F., Lambert B., et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23 (2002) 599-603
21. Liang G., Xing D., Miao X., Tan W., Yu C., Lu W., et al. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 105 (2003) 669-673
22. Park D.J., Stoehlmacher J., Zhang W., Tsao-Wei D.D., Groshen S., and Lenz H.J. A xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 61 (2001) 8654-8658
23. Camps C., Sarries C., Roig B., Sanchez J.J., Queralt C., Sancho E., et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer 4 (2003) 237-241
24. Shintani S., Matsuo K., Crohin C.C., McBride J., Tsuji T., Donoff R.B., et al. Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res 59 (1999) 4142-4147
25. Kennon B., Ingram M.C., Friel E.C., Anderson N.H., MacKenzie S.M., Davies E., et al. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 61 (2004) 174-181
26. Mechanic L.E., Millikan R.C., Player J., de Cotret A.R., Winkel S., Worley K., et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27 (2006) 1377-1385
27. Hu Z., Wei Q., Wang X., and Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 46 (2004) 1-10
28. Jiao L., Hassan M.M., Bondy M.L., Abbruzzese J.L., Evans D.B., and Li D. The XPD Asp(312)Asn and Lys(751)Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett 245 (2007) 61-68
29. Han J., Colditz G.A., Liu J.S., and Hunter D.J. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1539-1544
30. Olshan A.F., Shaw G.M., Millikan R.C., Laurent C., and Finnell R.H. Polymorphisms in DNA repair genes as risk factors for spina bifida and orofacial clefts. Am J Med Genet A 135 (2005) 268-273
31. Liu G., Zhou W., Yeap B.Y., Su L., Wain J.C., Poneros J.M., et al. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis 28 (2007) 1254-1258
32. Schabath M.B., Delclos G.L., Grossman H.B., Wang Y., Lerner S.P., Chamberlain R.M., et al. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 878-884
33. Yeh C.C., Sung F.C., Tang R., Chang-Chieh C.R., and Hsieh L.L. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 5 (2005) 12
34. Kietthubthew S., Sriplung H., Au W.W., and Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209 (2006) 21-29
35. Costa S., Pinto D., Pereira D., Rodrigues H., Cameselle-Teijeiro J., Medeiros R., et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103 (2007) 209-217
36. Gal T.J., Huang W.Y., Chen C., Hayes R.B., and Schwartz S.M. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 115 (2005) 2221-2231
37. Mehta P.A., Alonzo T.A., Gerbing R.B., Elliott J.S., Wilke T.A., Kennedy R.J., et al. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. Blood 107 (2006) 39-45
38. Guven M., Unal M., Batar B., Eroglu E., Devaroglu K., Tamcelik N., et al. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG). Mol Vis 13 (2007) 12-17